Skip to main content
# Title Research Member Research Year
11 Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 Dr. Iman Hassan Ahmed Hamada 2022
12 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
13 Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients Dr. Asmaa Mohamed Zahran Omar 2022
14 Genetic variation in FOXP3 and ROR‑γ genes in pediatric acute lymphocytic leukemia (ALL) patients: correlation with associated cytokines Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
15 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Dr. Noha gaber sayed 2022
16 T-lymphocytes expression of Toll-like receptors 2 and 4 in acute myeloid leukemia patients with invasive fungal infections Dr. Samar Muhammad mansour 2022
17 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia maureen raafat 2022
18 T-lymphocytes expression of Toll-like receptors 2 and 4 in acute myeloid leukemia patients with invasive fungal infections Dr. Abeer Mostafa Mostafa Darwish 2022
19 Regulatory T-lymphocyte subsets in children with chronic immune thrombocytopenia after high-dose of dexamethasone Dr. Asmaa Mohamed Zahran Omar 2022
20 Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells Dr. Mohamed Galal Mostafa ELnaggar 2022